JFS Wealth Advisors’s VanEck Biotech ETF BBH Stock Holding History

JFS Wealth Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150	Closed	-$28.2K	–	2255
2026 Q1	$28.2K	Buy	+150	New	+$28.9K	﹤0.01%	651

Other funds holding BBH

Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return

Value Investment Professionals New York $119M AUM

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

JFS Wealth Advisors's BBH Position: Q2 2026 in Review

JFS Wealth Advisors sold out of VanEck Biotech ETF (BBH) in Q2 2026, closing a stake of 150 shares — an estimated $28.2K sold.

JFS Wealth Advisors first reported a position in BBH in Q1 2026 and held it in 1 quarter. The position peaked at $28.2K in Q1 2026. 7 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

JFS Wealth Advisors reported no remaining VanEck Biotech ETF position as of Q2 2026 after selling out during the quarter.
JFS Wealth Advisors sold 150 VanEck Biotech ETF shares in Q2 2026, an estimated $28.2K.
JFS Wealth Advisors first reported a position in VanEck Biotech ETF in Q1 2026 and held it in 1 quarter.
JFS Wealth Advisors's VanEck Biotech ETF position peaked at $28.2K in Q1 2026.
7 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.